CYP3A5 CONTRIBUTION TO BUDESONIDE TREATMENT FAILURE IN CHILDREN WITH EOSINOPHILIC ESOPHAGITIS.

被引：0
|
作者：
Chevalier, R. [1 ,2 ]
Shakhnovich, V. [1 ,2 ,3 ]
Gaedigk, R. [1 ]
Pirani, K. [1 ]
Noel-MacDonnell, J. [1 ]
机构：
[1] Childrens Mercy Kansas City, Kansas City, MO USA
[2] Univ Missouri, Kansas City, MO 64110 USA
[3] Ctr Childrens Hlth Lifestyles & Nutr, Kansas City, MO USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2021年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-047
引用
收藏
页码：S19 / S20
页数：2
相关论文
共 50 条
  • [21] Treatment of eosinophilic esophagitis in children
    Ngo P.
    Furuta G.T.
    Current Treatment Options in Gastroenterology, 2005, 8 (5) : 397 - 403
  • [22] A New Viscous Budesonide Formulation for the Treatment of Eosinophilic Esophagitis in Children: A Preliminary Experience and Review of the Literature
    Warzecha, Joanna
    Dziekiewicz, Marcin
    Bienkowska-Tokarczyk, Alicja
    Malecki, Maciej
    Banaszkiewicz, Aleksandra
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (22)
  • [23] Oral viscous budesonide: A potential new therapy for eosinophilic esophagitis in children
    Aceves, Seema S.
    Bastian, John F.
    Newbury, Robert O.
    Dohil, Ranjan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (10): : 2271 - 2279
  • [24] Adrenal Suppression in Children Treated with Oral Viscous Budesonide for Eosinophilic Esophagitis
    Harel, Shira
    Hursh, Brenden E.
    Chan, Edmond S.
    Avinashi, Vishal
    Panagiotopoulos, Constadina
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [25] Limited contribution of CYP3A5 to the hepatic 6β-hydroxylation of testosterone
    Landry K. Kamdem
    Ingolf Meineke
    Ina Koch
    Ulrich M. Zanger
    Jürgen Brockmöller
    Leszek Wojnowski
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2004, 370 : 71 - 77
  • [26] Adrenal Suppression in Children Treated With Oral Viscous Budesonide for Eosinophilic Esophagitis
    Harel, Shira
    Hursh, Brenden E.
    Chan, Edmond S.
    Avinashi, Vishal
    Panagiotopoulos, Constadina
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2015, 61 (02): : 190 - 193
  • [27] Limited contribution of CYP3A5 to the hepatic 6β-hydroxylation of testosterone
    Kamdem, LK
    Meineke, I
    Koch, I
    Zanger, UM
    Brockmöller, J
    Wojnowski, L
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 370 (01) : 71 - 77
  • [28] The contribution of CYP3a4 and CYP3A5 on the metabolism of sildenafil, vardenafil, and udenafil.
    Ku, H.
    Bae, S.
    Seo, K.
    Ahn, H.
    Bae, S.
    Shon, J.
    Liu, K.
    Shin, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S49 - S49
  • [29] Characteristics of Children with Failure to Thrive and Eosinophilic Esophagitis
    Kerber, Alyssa
    Dierkhising, Ross
    Alexander, Jeffrey
    Katzka, David
    Ravi, Anupama
    Hopson, Puanani
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB89 - AB89
  • [30] An alternative treatment for eosinophilic esophagitis in children
    Nature Clinical Practice Gastroenterology & Hepatology, 2008, 5 (1): : 7 - 7
12345